New Crohn's Disease Study Findings Have Been Reported by Investigators at Mayo Clinic (A Multicenter Study of the Real-world Effectiveness and Safety of Risankizumab In Crohn's Disease)

Press/Media

Period18 Jun 2025

Media coverage

1

Media coverage

  • TitleNew Crohn's Disease Study Findings Have Been Reported by Investigators at Mayo Clinic (A Multicenter Study of the Real-world Effectiveness and Safety of Risankizumab In Crohn's Disease)
    Media name/outletImmunotherapy Daily
    Country/TerritoryUnited States
    Date18/06/25
    PersonsDavid Dulaney, Anish Patel
View all 1
View less

Related content